CLASS III Drug recall · Reported 3 Sep 2014 · FDA Enforcement Report
Nicotine Polacrilex Lozenge, 2 mg Mint Mini recalled by Perrigo Holland
Perrigo Holl is recalling Nicotine Polacrilex Lozenge, 2 mg Mint Mini, distributed in 7 states. The recall was initiated on 19 Aug 2014 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1558-2014
- FDA event ID
- 69048
- Recalling firm
- Perrigo Holl, Holland, MI
- Brand
- Careone Nicotine
- Manufacturer
- American Sales Company
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 19 Aug 2014
- FDA classified
- 22 Aug 2014
- Reported
- 3 Sep 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Telephone
- Reason category
- Potency & Assay
- Drug class
- Cold & Cough Medicine
Timeline
| 19 Aug 2014 | Recall initiated by company | |
| 22 Aug 2014 | Classified by FDA | +3 days |
| 3 Sep 2014 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Dissolution Specifications and Failed Tablet Specifications: High 30 minute dissolution test and presence of broken lozenges.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Nicotine Polacrilex Lozenge, 2 mg Mint Mini. 27 Ct Tubes, Over the Counter. Perrigo, 502 Eastern Ave, Plant #6, Allegan, MI 49010. Labeled: A) CareOne, 81 and 108 Ct Cartons, Distributed by: Foodhold U.S.A., LLD, Landover, MD 20785, NDC: 41520-734-02, 41520-734-03, B) CVS Pharmacy, 81 Ct Cartons, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, NDC: 59779-734-02, C) equate, 27, 108, and 135 Ct Cartons, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC: 49035-734-01, 49035-734-03, 49035-734-04, D) Kroger, 81 Ct Cartons, Distributed by: The Kroger Co., Cincinnati, Ohio 45202, NDC: 30142-734-02, E) Rite Aid, 81 and 108 Ct Cartons, Distributed by: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011, NDC: 11822-0734-3, 11822-0734-2, F) TopCare, 81 Ct Cartons, Distributed by Topco Associates LLC., Elk Grove Villiage, IL 60007, NDC: 36800-734-60 G) Walgreens, 81 and 135 Ct Cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC: 0363-0734-02, 0363-0374-04, H) 20 Ct Stretchcard, Target Corporation, Minneapolis, MN 55403. NDC: 11673-734-02.
Where it was distributed
U.S. Distribution: OH, RI, OR, PA, MN, IL, AR.
ArkansasIllinoisMinnesotaOhioOregonPennsylvaniaRhode Island
Stores named: Walmart, Kroger, Target, Walgreens, CVS, Rite Aid
Questions about this recall
Why was it recalled?
Failed Dissolution Specifications and Failed Tablet Specifications: High 30 minute dissolution test and presence of broken lozenges.
Which lots are affected?
Cartons of 27 ct Tubes: Lot #: 2MV1074, Expiry: 09/14; Lot #: 2MV1124, Expiry: 09/14; Lot #: 2MV1142, Expiry: 09/14; Lot #: 2MV1143, Expiry: 09/14; Lot #: 3AV0528, Expiry: 09/14; Lot #: 3FV0575, Expiry: 09/14; Lot #: 3FV0535, Expiry: 03/15; Lot #: 3FV0537, Expiry: 03/15; Lot #: 3FV0576, Expiry: 03/15; Lot #: 3FV0579, Expiry: 03/15; Lot #: 3FV0615, Expiry: 03/15; Lot #: 3FV0739, Expiry: 03/15; Lot #: 3FV0742, Expiry: 03/15, Lot #: 3GV0713, Expiry: 03/15; Lot #: 3GV0715, Expiry: 03/15, Lot #: 3FV0421, Expiry: 03/15, Lot #: 3FV0422, Expiry: 03/15; Lot #: 3FV0423, Expiry: 03/15; Lot #: 3FV0740, Expiry: 03/15. 20 Ct Stretchcard: Lot #: 3FV0520, Expiry: 03/15.
Where was it sold?
U.S. Distribution: OH, RI, OR, PA, MN, IL, AR.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other Nicotine Polacrilex recalls
All 13| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Nicotine polacrilex lozenge, 4 mg, Cherry Flavor cartons recalled | GlaxoSmithKline Consumer Healthcare; | Potency & Assay | Nationwide |
| Drug | CLASS III | Nicotine polacrilex lozenge, 2 mg, Mint Flavor cartons recalled | GlaxoSmithKline Consumer Healthcare; | Potency & Assay | Nationwide |
| Drug | CLASS III | Nicotine polacrilex lozenge, 4 mg, Mint Flavor recalled | GlaxoSmithKline Consumer Healthcare; | Potency & Assay | Nationwide |
| Drug | CLASS III | Nicorette (nicotine polacrilex) Lozenges Mini, 2 mg recalledNicorette | GlaxoSmithKline Consumer Healthcare; | Potency & Assay | Nationwide |
| Drug | CLASS III | Nicotine polacrilex lozenge, 4 mg, Original Flavor cartons recalledNicorette | GlaxoSmithKline Consumer Healthcare; | Potency & Assay | Nationwide |